Hanna Tormilainen

Interventional cardiologist / Cardiologist
Lappi Central Hospital - ROVANIEMI, Finland

Latest contributions

Left main stenting techniques

21 May 2025 – From EuroPCR 2025

Examine advanced left main stenting techniques including DK crush and mini-crush strategies for complex bifurcation lesions. This session reviews stent malapposition in trifurcations, novel stent expansion outcomes, bifurcation angle correlations, and clinical results of double kissing crush versus culotte techniques.

Left main stenting techniques

ACS: multimodality imaging saves the day

16 May 2024 – From EuroPCR 2024

This session explores various challenging acute coronary syndrome (ACS) cases where multimodality imaging, such as emergency cardiac CT, IVUS, and other techniques, played a crucial role in diagnosis and management. The cases cover a wide range of scenarios, including right coronary artery ACS, STEMI with a...

ACS: multimodality imaging saves the day

Innovative approaches to rare PCI complications in NSTEMI

16 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....

Innovative approaches to rare PCI complications in NSTEMI

Close call! Complex ACS cases

18 May 2023 – From EuroPCR 2023

Consult this session if you want to learn how to handle complications during NSTEMI treatment, to learn about unusual causes of ACS, and to learn about primary PCI in patients with coronary ectasia/aneurysms.

Close call! Complex ACS cases

How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor

17 May 2023 – From EuroPCR 2023

Discover the optimal approach to peri-percutaneous coronary intervention (PCI) antiplatelet treatment in clinical practice with a focus on the novel agent cangrelor. Gain a deeper understanding of the rationale behind cangrelor's use in various PCI settings, learn about the current recommendations and practices for its administration...

How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor